← Evidence map

TrialCardiovascular diabetology2024

Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.

Emmanouil Vrentzos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2024
2025
2026
this papertrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 38987784